Found: 27
Select item for more details and to access through your institution.
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 6, p. 589, doi. 10.1007/s11912-023-01394-5
- By:
- Publication type:
- Article
Approach to the Patient: New Era Emerges for Craniopharyngioma Management.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 11, p. 2986, doi. 10.1210/clinem/dgae503
- By:
- Publication type:
- Article
Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4954, doi. 10.3390/ijms21144954
- By:
- Publication type:
- Article
A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 13, p. 4754, doi. 10.3390/ijms21134754
- By:
- Publication type:
- Article
What matters for people with brain cancer? Selecting clinical quality indicators for an Australian Brain Cancer Registry.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 1, p. 68, doi. 10.1093/nop/npab055
- By:
- Publication type:
- Article
Barriers and potential solutions to international collaboration in neuro‐oncology clinical trials: Challenges from the Australian perspective.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 259, doi. 10.1111/ajco.13606
- By:
- Publication type:
- Article
Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.576027
- By:
- Publication type:
- Article
Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.
- Published in:
- Current Neurology & Neuroscience Reports, 2023, v. 23, n. 6, p. 263, doi. 10.1007/s11910-023-01268-0
- By:
- Publication type:
- Article
Impact of travel distance on outcomes for clinical trial patients: the Kinghorn Cancer Centre experience.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 2, p. 242, doi. 10.1111/imj.15561
- By:
- Publication type:
- Article
Measuring the Impact of an Adolescent and Young Adult Program on Addressing Patient Care Needs.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2018, v. 7, n. 5, p. 612, doi. 10.1089/jayao.2018.0015
- By:
- Publication type:
- Article
'The Reports of My Death Are Greatly Exaggerated'—Evaluating the Effect of Necrosis on MGMT Promoter Methylation Testing in High-Grade Glioma.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1906, doi. 10.3390/cancers16101906
- By:
- Publication type:
- Article
PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1003, doi. 10.3390/cancers14041003
- By:
- Publication type:
- Article
Exploring the Role of Novel Medical Therapies for Aggressive Pituitary Tumors: A Review of the Literature—"Are We There Yet?".
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 308, doi. 10.3390/cancers12020308
- By:
- Publication type:
- Article
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 4918, doi. 10.1002/cam4.3228
- By:
- Publication type:
- Article
Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 13, p. 4640, doi. 10.1002/cam4.3116
- By:
- Publication type:
- Article
Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 9, p. 3023, doi. 10.1002/cam4.2948
- By:
- Publication type:
- Article
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 2816, doi. 10.1002/cam4.1493
- By:
- Publication type:
- Article
Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta‐analysis.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 1, p. 1, doi. 10.1111/exd.14978
- By:
- Publication type:
- Article
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 10, p. 1736, doi. 10.1093/neuonc/noab111
- By:
- Publication type:
- Article
CBMT-06. LOWER GRADE ISOCITRATE DEHYDROGENASE (IDH) MUTANT GLIOMAS METABOLICALLY MIMICKING GLIOBLASTOMA (GBM) EXPRESS HIGHER R:S 2-HYDROXYGLUTARATE RATIOS RELATIVE TO NON-GBM-MIMICKING IDH MUTANT GLIOMAS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi33, doi. 10.1093/neuonc/noy148.125
- By:
- Publication type:
- Article
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad124
- By:
- Publication type:
- Article
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 1, p. 57, doi. 10.1002/ijc.31039
- By:
- Publication type:
- Article
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Altered presentation of oropharyngeal cancer, a 6‐year review.
- Published in:
- ANZ Journal of Surgery, 2021, v. 91, n. 6, p. 1240, doi. 10.1111/ans.16537
- By:
- Publication type:
- Article
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
- Published in:
- Oncology, 2021, v. 99, n. 1, p. 49, doi. 10.1159/000510446
- By:
- Publication type:
- Article
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers.
- Published in:
- Current Oncology, 2022, v. 29, n. 12, p. 9928, doi. 10.3390/curroncol29120781
- By:
- Publication type:
- Article